Privatsphäre-Einstellungen

Total Quality Management -eine Chance auch für die pharmazeutische Industrie

Dr. Andreas Ikker^a und Heinz Gaugler^b

Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim/Rhein^a, und Concito Gesellschaft für Unternehmensentwicklung mbH BDU, Ottobrunn^b

Total Quality Management (TQM), in other words, fundamental management, will become more important also for the pharmaceutical industry in the future. Due to stronger competition caused by the globalisation of markets, companies must further develop their GxP-based quality assurance system. Not the varieties of methods and instruments but the company’s general orientations originating from common sense is the basis for a successfull TQM.
The following paper presents these general orientations, which are also valid for the pharmaceutical industry, and discusses their impact for the companies. The management plays an outstanding role. Words about quality are not sufficient. Whether the management’s attitude represents the company’s orientations is crucial. However, a change of paradigms will be necessary for most of the managers. If this takes place, the company will be able to benefit from the whole potential behind TQM.